Lixte Biotechnology Holdings (LIXT)
NASDAQ:LIXT
Holding LIXT?
Track your performance easily

Lixte Biotechnology Holdings (LIXT) Financial Statements

66 Followers

Lixte Biotechnology Holdings Financial Overview

Lixte Biotechnology Holdings's market cap is currently ―. The company's EPS TTM is $-1.831; its P/E ratio is -0.90; Lixte Biotechnology Holdings is scheduled to report earnings on April 27, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.01M$ 969.62K$ -1.02M$ -1.67M$ 1.38M
EBITDA$ -1.01M$ 969.62K$ -1.02M$ -1.67M$ 1.38M
Net Income Common Stockholders$ -1.01M$ -971.32K$ -1.03M$ -1.33M$ 1.37M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.60M$ 3.41M$ 4.20M$ 2.91M$ 4.09M
Total Assets$ 2.67M$ 3.59M$ 4.31M$ 3.10M$ 4.33M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.60M$ -3.41M$ -4.20M$ -2.91M$ -4.09M
Total Liabilities$ 421.46K$ 246.69K$ 313.86K$ 402.61K$ 249.99K
Stockholders Equity$ 2.25M$ 3.13M$ 3.99M$ 2.69M$ 4.08M
Cash Flow-
Free Cash Flow$ -819.04K$ -789.23K$ -902.12K$ -1.18M$ -1.27M
Operating Cash Flow$ -819.04K$ -789.23K$ -902.12K$ -1.18M$ -1.27M
Investing Cash Flow-----
Financing Cash Flow----$ 6.28K
Currency in USD

Lixte Biotechnology Holdings Earnings and Revenue History

Lixte Biotechnology Holdings Debt to Assets

Lixte Biotechnology Holdings Cash Flow

Lixte Biotechnology Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis